Skip to main content

Bruker Not in Nasdaq Compliance Following Resignation

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker is not in compliance with a Nasdaq regulation following the resignation of Collin D'Silva, an independent director and member of the firm's audit committee.

Bruker said in a filing with the US Securities and Exchange Commission on Friday that D'Silva had resigned his position on the audit committee as of March 9. As a result, the firm currently has only two members of its audit committee and is no longer in compliance with a Nasdaq rule that requires a company's audit committee to have a minimum of three members.

Bruker said that has until Sep. 7 to regain compliance with the Nasdaq rule, and added that it intends to fill the vacancy "as expeditiously as possible" prior to Sep. 7.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.